Glaxosmithkline Pharmaceuticals informs about annual secretarial compliance report

19 May 2021 Evaluate

In compliance with the provisions of Regulation 24A of SEBI LODR Amendment Regulations, 2018, read with SEBI Circular dated February 08, 2019, Glaxosmithkline Pharmaceuticals has informed that it has enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March 2021.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2543.40 0.30 (0.01%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×